IN2012DN00546A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN00546A IN2012DN00546A IN546DEN2012A IN2012DN00546A IN 2012DN00546 A IN2012DN00546 A IN 2012DN00546A IN 546DEN2012 A IN546DEN2012 A IN 546DEN2012A IN 2012DN00546 A IN2012DN00546 A IN 2012DN00546A
- Authority
- IN
- India
- Prior art keywords
- derivatives
- pharmaceutical compositions
- tazarotene
- making
- subject matter
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/327—Peroxy compounds, e.g. hydroperoxides, peroxides, peroxyacids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4436—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21379409P | 2009-07-16 | 2009-07-16 | |
| US27225709P | 2009-09-04 | 2009-09-04 | |
| PCT/US2010/042225 WO2011009023A1 (en) | 2009-07-16 | 2010-07-16 | Tazarotene derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN00546A true IN2012DN00546A (de) | 2015-06-12 |
Family
ID=43449815
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN546DEN2012 IN2012DN00546A (de) | 2009-07-16 | 2010-07-16 |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US20120115909A1 (de) |
| EP (1) | EP2453746A4 (de) |
| JP (1) | JP5635090B2 (de) |
| KR (1) | KR101536806B1 (de) |
| CN (1) | CN102595892B (de) |
| AU (1) | AU2010273261B2 (de) |
| BR (1) | BR112012001680A2 (de) |
| CA (1) | CA2768015C (de) |
| EA (1) | EA022322B1 (de) |
| IL (1) | IL217519A (de) |
| IN (1) | IN2012DN00546A (de) |
| MX (1) | MX2012000768A (de) |
| NZ (1) | NZ598240A (de) |
| SG (1) | SG177579A1 (de) |
| WO (1) | WO2011009023A1 (de) |
| ZA (1) | ZA201200253B (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201105050D0 (en) * | 2011-03-25 | 2011-05-11 | Iiaa Ltd | Pharmaceutical agent |
| BR112013033309B1 (pt) * | 2011-06-24 | 2022-07-05 | Gri Bio, Inc | Uso de tazaroteno e método in vitro para inibição de ativação de células nkt tipo i |
| CN106918676B (zh) * | 2015-12-24 | 2020-08-11 | 重庆华邦制药有限公司 | 分离测定他扎罗汀倍他米松乳膏中两种药物含量及有关物质的方法 |
| WO2017152725A1 (zh) * | 2016-03-11 | 2017-09-14 | 中国科学院上海有机化学研究所 | 一种视黄酸类化合物、其制备方法、中间体及应用 |
| CN107176945B (zh) * | 2016-03-11 | 2021-06-08 | 中国科学院上海有机化学研究所 | 一种视黄酸类化合物、其制备方法、中间体及应用 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4801593A (en) * | 1979-09-13 | 1989-01-31 | Burroughs Wellcome Co. | Chemotherapeutic agents |
| US4980369A (en) | 1989-09-19 | 1990-12-25 | Allergan, Inc. | Acetylenes disubstituted with a phenyl group and a 2-substituted chromanyl or thiochromanyl group having retinoid-like activity |
| US5183827A (en) * | 1989-09-19 | 1993-02-02 | Allergan, Inc. | Acetylenes disubstituted with a heteroaromatic group and a 2-substituted chromanyl, thiochromanyl or 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity |
| US5045551A (en) | 1989-09-19 | 1991-09-03 | Allergan, Inc. | Acetylenes disubstituted with a heteroaromatic group and a 2-substituted chromanyl, thiochromanyl or 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity |
| US5272156A (en) | 1989-09-19 | 1993-12-21 | Allergan, Inc. | Acetylenes disubstituted with a heteroaromatic group and a 2-substituted 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity |
| US5162546A (en) | 1989-09-19 | 1992-11-10 | Allergan, Inc. | Acetylenes disubstituted with a phenyl group and a 2-substituted chromanyl, thiochromanyl or 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity |
| US5399561A (en) * | 1989-09-19 | 1995-03-21 | Allergan, Inc. | Acetylenes disubstituted with a phenyl or heteroaryl group and a 2-oxochromanyl, 2-oxothiochromanyl or 2-oxo-1,2,3,4-tetrahydro-quinolinyl group having retinoid-like biological activity |
| WO1992006084A1 (en) | 1990-10-09 | 1992-04-16 | Allergan, Inc. | Chromans and thiochromans with retinoid-like activity |
| JP3062248B2 (ja) | 1991-02-13 | 2000-07-10 | アラーガン、インコーポレイテッド | レチノイド様生物学的活性を有する７位にフェニルエチニル置換基を有するクロマンおよびチオクロマン |
| EP0577737A1 (de) | 1991-03-26 | 1994-01-12 | Allergan, Inc. | Chromane und thiochromane mit heteroarylethinylsubstituenten in der 7-position mit retinoidahnlicher wirkung |
| US6448233B1 (en) * | 1997-07-08 | 2002-09-10 | Cosmoferm B.V. | Topical application of a combination of benzoyl peroxide and a second active ingredient |
| ES2279624T3 (es) * | 1998-07-28 | 2007-08-16 | Susan Bershad | Tratamiento de contacto breve del acne y fotoenvejecimiento con retinoides topicos. |
| US6048902A (en) * | 1999-02-12 | 2000-04-11 | Lebwohl; Mark G. | Short contact treatment of psoriasis with topical retinoids |
| FR2830449B1 (fr) * | 2001-10-05 | 2004-04-23 | Fabre Pierre Dermo Cosmetique | Utilisation du tazarotene pour la preparation d'un vernis a ongles pour le traitement et/ou la prevention du psoriasis et un vernis a ongles le contenant |
| CN1210041C (zh) * | 2003-09-29 | 2005-07-13 | 中国医学科学院皮肤病研究所 | 治疗痤疮的复方外用药物 |
| ITMI20050357A1 (it) * | 2005-03-08 | 2006-09-09 | Solmag S P A | Procedimento di preparazione del tazarotene |
| AR054805A1 (es) * | 2005-06-29 | 2007-07-18 | Stiefel Laboratories | Composiciones topicas para el tratamiento de la piel |
| US9107844B2 (en) * | 2006-02-03 | 2015-08-18 | Stiefel Laboratories Inc. | Topical skin treating compositions |
| MXPA06008988A (es) | 2006-08-08 | 2008-02-07 | Fernando Ahumada Ayala | Preparaciones topicas antiacne que contienen retinoide (tazaroteno o adapaleno), antibiotico (fosfato de clindamicina) y/o queratolitico (peroxido de bonzoilo en microesponjas). |
| MX2009008250A (es) * | 2007-02-01 | 2009-08-27 | Sol Gel Technologies Ltd | Composiciones para aplicacion topica que comprenden un peroxido y retinoide. |
-
2010
- 2010-07-16 JP JP2012520808A patent/JP5635090B2/ja not_active Expired - Fee Related
- 2010-07-16 CN CN201080041425.7A patent/CN102595892B/zh not_active Expired - Fee Related
- 2010-07-16 MX MX2012000768A patent/MX2012000768A/es active IP Right Grant
- 2010-07-16 SG SG2012001509A patent/SG177579A1/en unknown
- 2010-07-16 NZ NZ598240A patent/NZ598240A/xx not_active IP Right Cessation
- 2010-07-16 EP EP10800590.1A patent/EP2453746A4/de not_active Withdrawn
- 2010-07-16 AU AU2010273261A patent/AU2010273261B2/en not_active Ceased
- 2010-07-16 KR KR1020127003938A patent/KR101536806B1/ko not_active IP Right Cessation
- 2010-07-16 EA EA201270176A patent/EA022322B1/ru not_active IP Right Cessation
- 2010-07-16 BR BRBR112012001680-6A patent/BR112012001680A2/pt not_active IP Right Cessation
- 2010-07-16 CA CA2768015A patent/CA2768015C/en not_active Expired - Fee Related
- 2010-07-16 US US13/383,869 patent/US20120115909A1/en not_active Abandoned
- 2010-07-16 WO PCT/US2010/042225 patent/WO2011009023A1/en active Application Filing
- 2010-07-16 IN IN546DEN2012 patent/IN2012DN00546A/en unknown
-
2012
- 2012-01-12 IL IL217519A patent/IL217519A/en not_active IP Right Cessation
- 2012-01-12 ZA ZA2012/00253A patent/ZA201200253B/en unknown
-
2014
- 2014-08-20 US US14/464,060 patent/US20140357669A1/en not_active Abandoned
- 2014-08-20 US US14/463,985 patent/US9062037B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| KR101536806B1 (ko) | 2015-07-14 |
| CN102595892A (zh) | 2012-07-18 |
| EA201270176A1 (ru) | 2012-08-30 |
| KR20120056821A (ko) | 2012-06-04 |
| SG177579A1 (en) | 2012-02-28 |
| EP2453746A4 (de) | 2013-04-24 |
| IL217519A (en) | 2015-06-30 |
| EA022322B1 (ru) | 2015-12-30 |
| BR112012001680A2 (pt) | 2015-09-01 |
| US20140357672A1 (en) | 2014-12-04 |
| NZ598240A (en) | 2013-10-25 |
| MX2012000768A (es) | 2012-02-13 |
| AU2010273261A1 (en) | 2012-02-02 |
| US20140357669A1 (en) | 2014-12-04 |
| ZA201200253B (en) | 2013-05-29 |
| EP2453746A1 (de) | 2012-05-23 |
| AU2010273261B2 (en) | 2013-07-25 |
| JP5635090B2 (ja) | 2014-12-03 |
| US20120115909A1 (en) | 2012-05-10 |
| CN102595892B (zh) | 2014-09-10 |
| JP2012533564A (ja) | 2012-12-27 |
| US9062037B2 (en) | 2015-06-23 |
| CA2768015A1 (en) | 2011-01-20 |
| CA2768015C (en) | 2016-03-15 |
| IL217519A0 (en) | 2012-02-29 |
| WO2011009023A1 (en) | 2011-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JO3199B1 (ar) | مركبات 5- فلورو-1h- بيرازولوبيريدينات مستبدلة واستخدامها | |
| MY156777A (en) | Substituted 2-acetamido-5-ary1-1,2,4-triazolones and use thereof | |
| MY169980A (en) | Bisaryl-linked aryltriazolones and their use | |
| MX364229B (es) | Composiciones y metodos para tratar enfermedades cardiovasculares. | |
| MX2021007268A (es) | Formas solidas de acido {[5-(3-clorofenil)-3-hidroxipiridin-2-carb onil]amino}acetico, composiciones, y usos de las mismas. | |
| IN2014DN09434A (de) | ||
| MX2012011771A (es) | Aptameros para beta-ngf y su uso en el tratamiento de enfermedades y trastornos mediados por beta-ngf. | |
| MX2012003770A (es) | Metodos para la modulacion de autofagia a traves de la modulacion de productos de genes que aumentan la autofagia. | |
| AU2011328009A8 (en) | Compounds and methods for treating pain | |
| NZ702977A (en) | 5-aminotetrahydroquinoline-2-carboxylic acids and use thereof | |
| EA201300669A1 (ru) | Замещенные 1-бензилциклоалкилкарбоновые кислоты и их применение | |
| MX2011007930A (es) | Conjugados de insulina cristalina. | |
| WO2012125544A3 (en) | Necroptosis inhibitors and methods of use therefor | |
| PH12014501967B1 (en) | Benzodioxanes in combination with other actives for inhibiting leukotriene production | |
| IL216967A0 (en) | 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseases | |
| WO2014015056A3 (en) | Anti-mucus drugs and uses therefor | |
| MX2012004078A (es) | Compuestos y composiciones como moduladores de la actividad de gpr119. | |
| EA201600096A1 (ru) | Бензил-1н-пиразол[3,4-b]пиридины и их применение | |
| CA2878796C (en) | Derivatives of pyridinone as inhibitors for tissue transglutaminase | |
| GB201213484D0 (en) | Pharmaceutical compositions comprising 15-OHEPA and methods of using the same | |
| IN2012DN00546A (de) | ||
| IN2014MN01542A (de) | ||
| MX2013003160A (es) | Composiciones farmaceuticas solidas antidiabeticas. | |
| MX2013002261A (es) | N-fenetiltriazolonacetamidas sustituidas y su uso. | |
| MX366309B (es) | Composicion farmaceutica para el tratamiento de inflamacion y dolor. |